Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Transplantation|August 7, 2018
Should Patients With NAFLD/NASH Be Surveyed for HCC?Maria Reig, Martina Gambato, Nancy Kwan Man, et al.
Journal of Hepatology|February 2, 2024
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practiceGiuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 30, 2022
Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic StudyKaterina Malagari, Alban Denys, Marta Burrel, et al.
Hepatology (Baltimore, Md.)|June 22, 2013
Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial designMaria Reig, Jordi Rimola, Ferran Torres, et al.
Journal of Hepatology|April 8, 2014
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenibMaria Reig, Ferran Torres, Carlos Rodriguez-Lope, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Pageof 9